Neostem (NBS -15.3%) trades sharply lower on the session. Perhaps weighing on the shares is a...

Neostem (NBS-15.3%) trades sharply lower on the session. Perhaps weighing on the shares is a paper by Stanford's Dr. Irving Weissman and others which questions the existence of pluripotent VSELs in mice.